Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -174,638 | -117,346 | -29,540 | -1,283 | -18,926 |
| Depreciation Amortization | 16,934 | 16,386 | 10,160 | 3,830 | 2,207 |
| Income taxes - deferred | 1,017 | 599 | -9,958 | -19,749 | -348 |
| Accounts receivable | -3,273 | 754 | 763 | -1,719 | -2,888 |
| Accounts payable and accrued liabilities | -3,852 | 1,829 | 1,247 | -1,784 | 1,498 |
| Other Working Capital | -2,112 | 3,939 | -5,271 | -918 | -12,773 |
| Other Operating Activity | 75,545 | 38,186 | 7,184 | 3,123 | 12,518 |
| Operating Cash Flow | $-90,379 | $-55,653 | $-25,415 | $-18,500 | $-18,712 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 0 | -809 | 0 | 0 |
| PPE Investments | -4,734 | -3,326 | -1,472 | -1,953 | -774 |
| Net Acquisitions | -1,683 | 20,528 | -19,092 | -28,186 | -1,323 |
| Purchase Of Investment | -589 | -17,441 | -3,396 | -2,013 | -650 |
| Sale Of Investment | 1,331 | 30,556 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 17,316 | -33 |
| Investing Cash Flow | $-5,675 | $30,317 | $-24,769 | $-14,836 | $-2,780 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 26,443 | 34,577 | 36,506 | 15,300 | 15,424 |
| Debt Issued | N/A | 170,184 | N/A | N/A | N/A |
| Common Stock Issued | 12,928 | 23,425 | 2,279 | 106,072 | 74 |
| Common Stock Repurchased | N/A | N/A | N/A | -7,832 | N/A |
| Dividend Paid | N/A | -3,015 | N/A | -4,704 | N/A |
| Other Financing Activity | -32,108 | -41,536 | -32,754 | -21,919 | -18,266 |
| Financing Cash Flow | $7,263 | $183,635 | $6,031 | $86,917 | $-2,768 |
| Exchange Rate Effect | -100 | 138 | -2 | -81 | -382 |
| Beginning Cash Position | 185,798 | 27,361 | 71,516 | 18,016 | 42,658 |
| End Cash Position | 96,907 | 185,798 | 27,361 | 71,516 | 18,016 |
| Net Cash Flow | $-88,891 | $158,437 | $-44,155 | $53,500 | $-24,642 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,379 | -55,653 | -25,415 | -18,500 | -18,712 |
| Capital Expenditure | -4,734 | -3,962 | -1,472 | -1,953 | -774 |
| Free Cash Flow | -95,113 | -59,615 | -26,887 | -20,453 | -19,486 |